HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant

BACKGROUND: Epidermal growth factor receptor (EGFR) has emerged as an important therapeutic target. Overexpression of EGFR is frequently observed in hepatocellular carcinoma (HCC) and EGFR activation has been proven to be a potential determinant of primary resistance of HCC cells to sorafenib. In ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Sueangoen, Natthaporn, Tantiwetrueangdet, Anchalee, Panvichian, Ravat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076995/
https://www.ncbi.nlm.nih.gov/pubmed/32190291
http://dx.doi.org/10.1186/s13578-020-00407-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076995/
https://www.ncbi.nlm.nih.gov/pubmed/32190291
http://dx.doi.org/10.1186/s13578-020-00407-1

Ejemplares similares